Clinical trials
Phase 4 Headache trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 6 |
| Recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Montefiore Medical Center | 4 |
| Cady, Roger, M.D. | 3 |
| Pfizer | 2 |
| University Medical Center of Southern Nevada | 2 |
| Albert Einstein Healthcare Network | 1 |
| Amgen | 1 |
| Antonios Likourezos | 1 |
| AstraZeneca | 1 |
| Chicago Headache Center & Research Institute | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Headache | 37 |
| Migraine Disorders | 19 |
| Post-Traumatic Headache | 4 |
| Emergencies | 2 |
| Tension-Type Headache | 2 |
| Abdominal Neoplasms | 1 |
| Aneurysm | 1 |
| Brain Concussion | 1 |
| Brain Injuries | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.